Social entrepreneur who built RAJE, a large educational non-profit and had the idea for InvestAcure when his daughter was battling cancer.

Worked with Max as the COO of RAJE and joined him in co-founding the new company. MBA & IT background.

31 years Wall Street investment banking and equity capital markets leadership, Founder, Chairman & CEO of Weild & Co., Former Vice Chairman of the NASDAQ, known as "The father of the JOBS Act", served as President & Head of Corporate Finance at Prudential.

NGN Capital, Co-founder & Managing General Partner, voted top pharmaceutical analyst by Institutional Investor Magazine, Wall Street Analyst Hall of Fame, MBA, Harvard Business School.

Experienced nonprofit & social impact executive, Founder of Nextdor, a social impact startup accelerator & Bizrael, a leading nonprofit connecting US & Israeli pharmaceutical & tech startups.

15 years Gamification and UI/UX design leadership for world's leading brands, including Google, LEGO, eBay, Huawei, and Volkswagen/Porsche.

25 years leading software development teams in building Core Banking, Wealth Management, Electronic Payments and Money Transfer platforms, worked with IBM & Microsoft in creating financial service & credit card processing systems for emerging markets.

5 years communications & development, Communication Officer @ Smith & Lewis Global, BA Political Science & Government Smith College

Editor-in-Chief of Journal of Alzheimer's, Dean UT-San Antonio, one of the top most-cited scientists in Neuroscience.

Director of the Banner Alzheimer’s Institute. Over 350 scientific papers, including several leading to FDA approval of treatments for Alzheimer's.

CSO of In Silico Biosciences, headed Johnson & Johnson Alzheimer’s research and developed one of only 5 approved Alzheimer’s drugs.

NIH and Alzheimer’s Association national panels. Over 50 publications, 5 patents, and more than 100 presentations at conferences.

Director of USC State of California Alzheimer’s Disease Center and the National Institute on Aging Alzheimer’s Disease Research Center. Editor-in-chief of Alzheimer’s & Dementia: Translational Research and Clinical Interventions.

A leading expert in early-stage drug discovery directed Exploratory & Translational Sciences at Merck, scientific board of Alzheimer's Drug Discovery Foundation, 144 research publications.

Columbia University – Director of MR Research – 45 patents – pioneer in development of MRI technology for diagnosis of Alzheimer’s.

Director at Center for Cognitive Medicine, Vanderbilt University. Lead consultant to pharmaceutical & biotechnology companies in the US and abroad on central nervous system drug development, clinical trial design for dementia & depression, & clinical nicotinic pharmacology.